These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 32050773)

  • 1. Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.
    Peng Y; Gao P; Shi L; Chen L; Liu J; Long J
    Antioxid Redox Signal; 2020 Jun; 32(16):1188-1236. PubMed ID: 32050773
    [No Abstract]   [Full Text] [Related]  

  • 2. Synaptic mitochondrial pathology in Alzheimer's disease.
    Du H; Guo L; Yan SS
    Antioxid Redox Signal; 2012 Jun; 16(12):1467-75. PubMed ID: 21942330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA
    Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease.
    Li Y; Xia X; Wang Y; Zheng JC
    J Neuroinflammation; 2022 Oct; 19(1):248. PubMed ID: 36203194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Mitochondria DNA Variation a Biomarker for AD?
    Gao R; Ma SL
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.
    Mi Y; Qi G; Brinton RD; Yin F
    Antioxid Redox Signal; 2021 Mar; 34(8):611-630. PubMed ID: 32143551
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    Guo L; Tian J; Du H
    J Alzheimers Dis; 2017; 57(4):1071-1086. PubMed ID: 27662318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
    Swerdlow RH
    J Alzheimers Dis; 2018; 62(3):1403-1416. PubMed ID: 29036828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS
    J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β.
    Huang Z; Yan Q; Wang Y; Zou Q; Li J; Liu Z; Cai Z
    J Alzheimers Dis; 2020; 78(2):505-514. PubMed ID: 33044180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
    Bonda DJ; Wang X; Perry G; Smith MA; Zhu X
    Drugs Aging; 2010 Mar; 27(3):181-92. PubMed ID: 20210366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for altered insulin receptor signaling in Alzheimer's disease.
    Griffith CM; Eid T; Rose GM; Patrylo PR
    Neuropharmacology; 2018 Jul; 136(Pt B):202-215. PubMed ID: 29353052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple defects in energy metabolism in Alzheimer's disease.
    Ferreira IL; Resende R; Ferreiro E; Rego AC; Pereira CF
    Curr Drug Targets; 2010 Oct; 11(10):1193-206. PubMed ID: 20840064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets.
    Song M; Fan X
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Ashleigh T; Swerdlow RH; Beal MF
    Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.